Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study

Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study

Abstract Background This study examined associations between receipt of hepatitis C (HCV) treatment and retention in office-based opioid treatment (OBOT) care. Methods We conducted a retrospective cohort study of HCV-infected patients who initiated OBOT treatment between December 2015 and March 2021...

Full description

Bibliographic Details
Main Authors: Mary L. Geist, Andrea C. Radick, Judith I. Tsui, Kendra L. Blalock, Addy Adwell, Elsabeth Tamru, Nancy C. Connolly, Jocelyn R. James
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Addiction Science & Clinical Practice
Subjects:
Hepatitis c treatment
Office-based buprenorphine treatment
Buprenorphine retention
Online Access:https://doi.org/10.1186/s13722-023-00389-8

Internet

https://doi.org/10.1186/s13722-023-00389-8

Similar Items